RecruitingPhase 4NCT06579001

Effect of Nasal Spray Dexmedetomidine on Emergence Delirium Prevention in Total Hip Replacement

Effect of Nasal Spray Dexmedetomidine on Emergence Delirium Prevention in Total Hip Replacement in the Elderly Under General Anesthesia: a Randomized Clinical Trial


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

264 participants

Start Date

Nov 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Emergence Delirium (ED) is a common postoperative complication refers to an acute brain dysfunction that occurs during the recovery from general anesthesia, which is mainly characterized by sudden attention and consciousness disorders. The occurrence of ED increases the risk of self-injury, wound dehiscence, accidental catheter dislocation, and postoperative delirium, and is also associated with postoperative cognitive deterioration and increased utilization of medical resources after discharge.


Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a nasal spray version of dexmedetomidine — a calming medication — given before surgery can prevent emergence delirium (a state of confusion and agitation that some patients experience right after waking from general anesthesia) in older adults having hip replacement surgery. **You may be eligible if...** - You are 60 years or older - You are scheduled for total hip replacement under general anesthesia - You are classified as ASA grade II or III (mild to moderate medical conditions) **You may NOT be eligible if...** - You have an allergy or contraindication to dexmedetomidine - You have severe nasal problems or a significantly deviated nasal anatomy - You have a very slow heart rate, serious heart block, severe heart failure, or a pacemaker - You have had a recent heart attack, stroke, or severe brain condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNasal spray dexmedetomidine

Nasal spray dexmedetomidine or saline was used 100ug per patient acording to the group assignment


Locations(1)

闗闗

Hangzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06579001


Related Trials